집 » 모두 » 주식 예측 » TScan Therapeutics Inc. Common Stock 예측

TScan Therapeutics Inc. Common Stock 예측: 내일, 주, 월, 5년

업데이트됨: April 22 · 2026 at 07:03 UTC

From

▼ -11.19%Market Cap $76.33M · Technical analysis Bearish · Focus area Price + volatility

예측 요약

기간	예상 가격	과거	역사적인	통찰력
내일	$1.30 ▲ +2.03%	어제	$1.26 ▼ -0.85%	Tomorrow's TScan Therapeutics Inc. Common Stock (TCRX) setup is anchored to $1.27 and targets $1.30 (+2.03%). The near-term read is upside; watch $1.31 / $1.23 because daily realized volatility is about 8.00%.
Tomorrow's TScan Therapeutics Inc. Common Stock (TCRX) setup is anchored to $1.27 and targets $1.30 (+2.03%). The near-term read is upside; watch $1.31 / $1.23 because daily realized volatility is about 8.00%.
주	$1.35 ▲ +6.31%	지난주	$1.24 ▼ -2.65%	The 7-day TScan Therapeutics Inc. Common Stock model moves from $1.24 to $1.35 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.31 / $1.23 matter more than a single tick.
The 7-day TScan Therapeutics Inc. Common Stock model moves from $1.24 to $1.35 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.31 / $1.23 matter more than a single tick.
월	$1.44 ▲ +13.45%	전달	$1.20 ▼ -5.65%	The 1-month TScan Therapeutics Inc. Common Stock target is $1.44 (+13.45%), compared with the live reference near $1.27. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month TScan Therapeutics Inc. Common Stock target is $1.44 (+13.45%), compared with the live reference near $1.27. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
년도	$1.58 ▲ +24.14%	작년	$1.14 ▼ -10.14%	The 1-year TScan Therapeutics Inc. Common Stock scenario points to $1.58 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year TScan Therapeutics Inc. Common Stock scenario points to $1.58 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5년	$1.89 ▲ +49.20%	5년 전	$1.01 ▼ -20.66%	The 5-year TScan Therapeutics Inc. Common Stock view is $1.89 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year TScan Therapeutics Inc. Common Stock view is $1.89 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

내일$1.30▲ +2.03%

어제$1.26▼ -0.85%

Tomorrow's TScan Therapeutics Inc. Common Stock (TCRX) setup is anchored to $1.27 and targets $1.30 (+2.03%). The near-term read is upside; watch $1.31 / $1.23 because daily realized volatility is about 8.00%.

주$1.35▲ +6.31%

지난주$1.24▼ -2.65%

The 7-day TScan Therapeutics Inc. Common Stock model moves from $1.24 to $1.35 (+6.31%). It gives upside momentum context for this stock, so breaks around $1.31 / $1.23 matter more than a single tick.

월$1.44▲ +13.45%

전달$1.20▼ -5.65%

The 1-month TScan Therapeutics Inc. Common Stock target is $1.44 (+13.45%), compared with the live reference near $1.27. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

년도$1.58▲ +24.14%

작년$1.14▼ -10.14%

The 1-year TScan Therapeutics Inc. Common Stock scenario points to $1.58 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5년$1.89▲ +49.20%

5년 전$1.01▼ -20.66%

The 5-year TScan Therapeutics Inc. Common Stock view is $1.89 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

가격 차트

역사적인예측강세약세

기술적 분석

Neutral

강세

중립적

약세

주요 지표

지시자	값	신호
Price	$1.27	Mid
Daily Change	-11.19%	Below
Volatility Cap	20.0%	Mid
Confidence	82%	Above
Data Source	nasdaq-screener	Mid

과거 데이터

Current$1.27

Daily Change-11.19%

Market Cap$76.33M

Sourcenasdaq-screener

Current	$1.27	Daily Change	-11.19%
Market Cap	$76.33M	Source	nasdaq-screener

지지 및 저항 수준

$1.23Support 1

$1.27현재의

$1.31Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

가격 이정표

주요 수준 및 역사적 맥락

Current$1.27Live reference price

Used as the anchor for generated forecast calculations.

Next Month$1.44Model projection+13.45%

Directional scenario based on capped drift.

예측 정확도

우리 모델의 성능

82%

방향성

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

우리의 알고리즘은 최신 가격 조치, 변동성 체제 및 지표 신호를 사용하여 매주 재보정됩니다. 정확도는 기간에 따라 다릅니다. 단기적인 모멘텀이 장기 예측보다 더 안정적입니다.

Short term

82%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

투자 시나리오

오늘 TCRX에 $1,000를 투자한다면

Bullish Scenario

$1.33

+5.00% from current

목표가격$1.33

대본Upside momentum

개연성62%

Base Scenario

$1.44

+13.45%

목표가격$1.44

대본Capped drift

개연성70%

Bearish Scenario

$1.21

-5.00% from current

목표가격$1.21

대본Volatility drawdown

개연성20%

기초: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

예측 요인

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 79/100

24H drift+2.03%

7D drift+6.31%

30D drift+13.45%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 75/100

1M outlook+13.45%

1Y outlook+24.14%

5Y outlook+49.20%

자주 묻는 질문

Q What is the TScan Therapeutics Inc. Common Stock (TCRX) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), TScan Therapeutics Inc. Common Stock is projected near $1.30 versus the current reference around $1.27. That implies a modeled move of +2.03% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for TCRX?

The weekly TScan Therapeutics Inc. Common Stock model points to $1.35, which maps to an expected drift of +6.31% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the TScan Therapeutics Inc. Common Stock 1-month and 1-year targets?

The TScan Therapeutics Inc. Common Stock 1-month target is $1.44 (+13.45%), while the 1-year target is $1.58 (+24.14%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the TScan Therapeutics Inc. Common Stock 5-year scenario differ from short-term rows?

The TScan Therapeutics Inc. Common Stock long-horizon scenario sits near $1.89 with a modeled change of +49.20%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are TCRX support and resistance zones right now?

For TScan Therapeutics Inc. Common Stock, nearest resistance is around $1.23, while nearest support is around $1.31. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the TScan Therapeutics Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.